| P50 | author | Peter Vandamme | Q21337596 |
| | Ramon A. Juste | Q38325489 |
| P2093 | author name string | J R Govan | |
| | E Berriatua | |
| | I Ziluaga | |
| | S Laevens | |
| | C Miguel-Virto | |
| | P Uribarren | |
| P2860 | cites work | Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov. and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary specimens | Q30915172 |
| | Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex | Q33179632 |
| | Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). | Q33179898 |
| | DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. | Q33181005 |
| | Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis | Q34058533 |
| | Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia | Q34291109 |
| | Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers | Q35579642 |
| | An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis | Q35885860 |
| | Regression analysis for correlated data | Q36764238 |
| | Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. | Q36886857 |
| | Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? | Q37092347 |
| | Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis | Q37137659 |
| | Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. | Q39460330 |
| | Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. | Q39510228 |
| | A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen | Q39511333 |
| | Invasion and intracellular survival of Burkholderia cepacia | Q39513566 |
| | Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes | Q39571092 |
| | Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis | Q39648598 |
| | Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. | Q39831246 |
| | Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. | Q39833239 |
| | Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? | Q40007382 |
| | Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium | Q40013162 |
| | Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. | Q40013318 |
| | Pseudomonas spp. associated vegetative endocarditis in two horses | Q40680343 |
| | Survival and growth of Burkholderia cepacia within the free-living amoeba Acanthamoeba polyphaga. | Q40771050 |
| | Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens | Q40908634 |
| | Burkholderia cepacia: medical, taxonomic and ecological issues | Q41260421 |
| | An outbreak of Pseudomonas mastitis in dairy cows | Q42143014 |
| | Biological activity ofBurkholderia (Pseudomonas) cepacialipopolysaccharide | Q43817916 |
| | Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients | Q45314740 |
| | Burkholderia cepacia. Management issues and new insights | Q48766893 |
| | Agricultural and medical microbiology: a time for bridging gaps. | Q54120507 |
| | Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. | Q54182171 |
| | The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain | Q64450132 |
| | Relationship between somatic cell count and intramammary infection of the half udder in dairy ewes | Q71174914 |
| | Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense | Q71662612 |
| | Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens | Q71698854 |
| | Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia | Q73819146 |
| | Lipopolysaccharide chemotypes of Burkholderia cepacia | Q78245629 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkholderia cepacia | Q139227 |
| P304 | page(s) | 990-994 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection | |
| P478 | volume | 39 | |